Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

1.240

+0.070 (5.98%)

At close: Feb 11, 2026, 4:00 PM EST

1.220

0.00 (0.00%)

Pre-market: Feb 12, 2026, 4:22 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Human Therapeutics	2.00M
Human Therapeutics Growth	23.08%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	2.00M
United States Growth	23.08%